Evolutionary trends in the prevalence of anti-HDV antibodies among patients positive for HBsAg referred to a national laboratory in Cameroon from 2012 to 2017
Abstract Objective The aim of this study was to update the data on the prevalence of anti-HDV antibodies in Cameroon. Results Antibodies against hepatitis Delta virus (Anti-HDV) were found in 16.48% (95% CI 11.46–18.77%) of 426 hepatitis B virus surface antigen positive patients in Cameroon. Remarka...
| Main Authors: | , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
BMC
2019-07-01
|
| Series: | BMC Research Notes |
| Subjects: | |
| Online Access: | http://link.springer.com/article/10.1186/s13104-019-4460-4 |
| id |
doaj-e542b2e9f1884cbdbd7ec2b024a64c3a |
|---|---|
| record_format |
Article |
| spelling |
doaj-e542b2e9f1884cbdbd7ec2b024a64c3a2020-11-25T03:01:05ZengBMCBMC Research Notes1756-05002019-07-011211610.1186/s13104-019-4460-4Evolutionary trends in the prevalence of anti-HDV antibodies among patients positive for HBsAg referred to a national laboratory in Cameroon from 2012 to 2017Laurence Noubissi-Jouegouo0Marie Amougou Atsama1Paul Alain Tagnouokam-Ngoupo2Chavely Gwladys Monamele3Laure Ngono4Richard Njouom5Virology Department, Centre Pasteur of CameroonVirology Department, Centre Pasteur of CameroonVirology Department, Centre Pasteur of CameroonVirology Department, Centre Pasteur of CameroonVirology Department, Centre Pasteur of CameroonVirology Department, Centre Pasteur of CameroonAbstract Objective The aim of this study was to update the data on the prevalence of anti-HDV antibodies in Cameroon. Results Antibodies against hepatitis Delta virus (Anti-HDV) were found in 16.48% (95% CI 11.46–18.77%) of 426 hepatitis B virus surface antigen positive patients in Cameroon. Remarkably, they were significantly higher among people over 40 years and those living in the East and South regions of Cameroon at 66.7%, 50%, and 40%, respectively. These results suggest that older age and living in areas in the dense forest may be risk factors for Hepatitis D infection.http://link.springer.com/article/10.1186/s13104-019-4460-4TrendsPrevalenceAnti-HDV antibodiesHBsAgCameroon |
| collection |
DOAJ |
| language |
English |
| format |
Article |
| sources |
DOAJ |
| author |
Laurence Noubissi-Jouegouo Marie Amougou Atsama Paul Alain Tagnouokam-Ngoupo Chavely Gwladys Monamele Laure Ngono Richard Njouom |
| spellingShingle |
Laurence Noubissi-Jouegouo Marie Amougou Atsama Paul Alain Tagnouokam-Ngoupo Chavely Gwladys Monamele Laure Ngono Richard Njouom Evolutionary trends in the prevalence of anti-HDV antibodies among patients positive for HBsAg referred to a national laboratory in Cameroon from 2012 to 2017 BMC Research Notes Trends Prevalence Anti-HDV antibodies HBsAg Cameroon |
| author_facet |
Laurence Noubissi-Jouegouo Marie Amougou Atsama Paul Alain Tagnouokam-Ngoupo Chavely Gwladys Monamele Laure Ngono Richard Njouom |
| author_sort |
Laurence Noubissi-Jouegouo |
| title |
Evolutionary trends in the prevalence of anti-HDV antibodies among patients positive for HBsAg referred to a national laboratory in Cameroon from 2012 to 2017 |
| title_short |
Evolutionary trends in the prevalence of anti-HDV antibodies among patients positive for HBsAg referred to a national laboratory in Cameroon from 2012 to 2017 |
| title_full |
Evolutionary trends in the prevalence of anti-HDV antibodies among patients positive for HBsAg referred to a national laboratory in Cameroon from 2012 to 2017 |
| title_fullStr |
Evolutionary trends in the prevalence of anti-HDV antibodies among patients positive for HBsAg referred to a national laboratory in Cameroon from 2012 to 2017 |
| title_full_unstemmed |
Evolutionary trends in the prevalence of anti-HDV antibodies among patients positive for HBsAg referred to a national laboratory in Cameroon from 2012 to 2017 |
| title_sort |
evolutionary trends in the prevalence of anti-hdv antibodies among patients positive for hbsag referred to a national laboratory in cameroon from 2012 to 2017 |
| publisher |
BMC |
| series |
BMC Research Notes |
| issn |
1756-0500 |
| publishDate |
2019-07-01 |
| description |
Abstract Objective The aim of this study was to update the data on the prevalence of anti-HDV antibodies in Cameroon. Results Antibodies against hepatitis Delta virus (Anti-HDV) were found in 16.48% (95% CI 11.46–18.77%) of 426 hepatitis B virus surface antigen positive patients in Cameroon. Remarkably, they were significantly higher among people over 40 years and those living in the East and South regions of Cameroon at 66.7%, 50%, and 40%, respectively. These results suggest that older age and living in areas in the dense forest may be risk factors for Hepatitis D infection. |
| topic |
Trends Prevalence Anti-HDV antibodies HBsAg Cameroon |
| url |
http://link.springer.com/article/10.1186/s13104-019-4460-4 |
| work_keys_str_mv |
AT laurencenoubissijouegouo evolutionarytrendsintheprevalenceofantihdvantibodiesamongpatientspositiveforhbsagreferredtoanationallaboratoryincameroonfrom2012to2017 AT marieamougouatsama evolutionarytrendsintheprevalenceofantihdvantibodiesamongpatientspositiveforhbsagreferredtoanationallaboratoryincameroonfrom2012to2017 AT paulalaintagnouokamngoupo evolutionarytrendsintheprevalenceofantihdvantibodiesamongpatientspositiveforhbsagreferredtoanationallaboratoryincameroonfrom2012to2017 AT chavelygwladysmonamele evolutionarytrendsintheprevalenceofantihdvantibodiesamongpatientspositiveforhbsagreferredtoanationallaboratoryincameroonfrom2012to2017 AT laurengono evolutionarytrendsintheprevalenceofantihdvantibodiesamongpatientspositiveforhbsagreferredtoanationallaboratoryincameroonfrom2012to2017 AT richardnjouom evolutionarytrendsintheprevalenceofantihdvantibodiesamongpatientspositiveforhbsagreferredtoanationallaboratoryincameroonfrom2012to2017 |
| _version_ |
1724695092480966656 |